Here, we also showed that the expression of BECN1 was lower in CRC samples than in adjacent normal tissues and was associated with poor prognosis in CRC, indicating that BECN1 could act as a suppressor and a novel prognostic marker for colon cancer patients. This evidence concerns the gene BECN1 and malignant colon neoplasm.